Switching from serum to KOSR caused a transient increase in reactive oxygen species and AKT phosphorylation in CML cells that were protected by KOSR but not in those that were not protected by this nutrient supplement. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.